Soc. Generale Knock-Out MRK/ DE000SH5QY17 /
03/05/2024 09:32:11 | Chg.-0.010 | Bid21:59:29 | Ask21:59:29 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.940EUR | -0.25% | 3.850 Bid Size: 6,000 |
3.860 Ask Size: 6,000 |
Merck and Co Inc | 86.4446 USD | 31/12/2078 | Call |
GlobeNewswire
24/04
IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire
15/04
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire
09/04
IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire
18/03
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D...
GlobeNewswire
15/03
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
06/03
IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Can...
GlobeNewswire
07/02
Alleo Labs Announces Publication on the Use of Artificial Intelligence in Neuroscience Drug Discover...
GlobeNewswire
09/01
C4 Therapeutics Announces 2024 Priorities and Extended Cash Runway to Advance Portfolio of Targeted ...
GlobeNewswire
21/12/2023
IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial
GlobeNewswire
04/12/2023
Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing Rule
GlobeNewswire
15/11/2023
Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies